aluates Reports

$ 0.0

Automative

Global Platinum Anti-tumor Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-27B4803

Global Platinum Anti tumor Drugs Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Platinum Anti-tumor Drugs Market Research Report 2025

Code: QYRE-Auto-27B4803

Report

July 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

Hengrui Medicine

ASK Pharma

Yi Bai Pharmaceutical

Qilu Pharmaceutical

TEVA

Pfizer Inc

Dr. Reddy’s Laboratories

Sun Pharma

Novartis

Debiopharm

Accord Healthcare

SK Chemicals

Viatris

Platinum Anti-tumor Drugs Market Size

The global market for Platinum Anti-tumor Drugs was valued at US$ 1622 million in the year 2024 and is projected to reach a revised size of US$ 1976 million by 2031, growing at a CAGR of 2.9% during the forecast period.

Platinum Anti-tumor Drugs Market

Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Platinum Anti-tumor Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum Anti-tumor Drugs.

The Platinum Anti-tumor Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Platinum Anti-tumor Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Platinum Anti-tumor Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Platinum Anti-tumor Drugs Market Report

Report Metric	Details
Report Name	Platinum Anti-tumor Drugs Market
Accounted market size in year	US$ 1622 million
Forecasted market size in 2031	US$ 1976 million
CAGR	2.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Cisplatin Oxaliplatin Carboplatin Other
Segment by Application	Colorectal Cancer Ovarian Cancer Lung Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical, Teva, Pfizer, Dr Reddy's Laboratories, Viatris, Sun Pharma, Novartis, Debiopharm, Accord Healthcare, SK Chemicals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Platinum Anti-tumor Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Platinum Anti-tumor Drugs Market growing?

Ans: The Platinum Anti-tumor Drugs Market witnessing a CAGR of 2.9% during the forecast period 2025-2031.

What is the Platinum Anti-tumor Drugs Market size in 2031?

Ans: The Platinum Anti-tumor Drugs Market size in 2031 will be US$ 1976 million.

Who are the main players in the Platinum Anti-tumor Drugs Market report?

Ans: The main players in the Platinum Anti-tumor Drugs Market are Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical, Teva, Pfizer, Dr Reddy's Laboratories, Viatris, Sun Pharma, Novartis, Debiopharm, Accord Healthcare, SK Chemicals

What are the Application segmentation covered in the Platinum Anti-tumor Drugs Market report?

Ans: The Applications covered in the Platinum Anti-tumor Drugs Market report are Colorectal Cancer, Ovarian Cancer, Lung Cancer, Other

What are the Type segmentation covered in the Platinum Anti-tumor Drugs Market report?

Ans: The Types covered in the Platinum Anti-tumor Drugs Market report are Cisplatin, Oxaliplatin, Carboplatin, Other

Recommended Reports

Cancer Drug Markets

Cancer Therapy Markets

Precision & Diagnostic

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Platinum Anti-tumor Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Cisplatin

1.2.3 Oxaliplatin

1.2.4 Carboplatin

1.2.5 Other

1.3 Market by Application

1.3.1 Global Platinum Anti-tumor Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Colorectal Cancer

1.3.3 Ovarian Cancer

1.3.4 Lung Cancer

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Platinum Anti-tumor Drugs Market Perspective (2020-2031)

2.2 Global Platinum Anti-tumor Drugs Growth Trends by Region

2.2.1 Global Platinum Anti-tumor Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Platinum Anti-tumor Drugs Historic Market Size by Region (2020-2025)

2.2.3 Platinum Anti-tumor Drugs Forecasted Market Size by Region (2026-2031)

2.3 Platinum Anti-tumor Drugs Market Dynamics

2.3.1 Platinum Anti-tumor Drugs Industry Trends

2.3.2 Platinum Anti-tumor Drugs Market Drivers

2.3.3 Platinum Anti-tumor Drugs Market Challenges

2.3.4 Platinum Anti-tumor Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Platinum Anti-tumor Drugs Players by Revenue

3.1.1 Global Top Platinum Anti-tumor Drugs Players by Revenue (2020-2025)

3.1.2 Global Platinum Anti-tumor Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Platinum Anti-tumor Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Platinum Anti-tumor Drugs Revenue

3.4 Global Platinum Anti-tumor Drugs Market Concentration Ratio

3.4.1 Global Platinum Anti-tumor Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Platinum Anti-tumor Drugs Revenue in 2024

3.5 Global Key Players of Platinum Anti-tumor Drugs Head office and Area Served

3.6 Global Key Players of Platinum Anti-tumor Drugs, Product and Application

3.7 Global Key Players of Platinum Anti-tumor Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Platinum Anti-tumor Drugs Breakdown Data by Type

4.1 Global Platinum Anti-tumor Drugs Historic Market Size by Type (2020-2025)

4.2 Global Platinum Anti-tumor Drugs Forecasted Market Size by Type (2026-2031)

5 Platinum Anti-tumor Drugs Breakdown Data by Application

5.1 Global Platinum Anti-tumor Drugs Historic Market Size by Application (2020-2025)

5.2 Global Platinum Anti-tumor Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Platinum Anti-tumor Drugs Market Size (2020-2031)

6.2 North America Platinum Anti-tumor Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Platinum Anti-tumor Drugs Market Size by Country (2020-2025)

6.4 North America Platinum Anti-tumor Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Platinum Anti-tumor Drugs Market Size (2020-2031)

7.2 Europe Platinum Anti-tumor Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Platinum Anti-tumor Drugs Market Size by Country (2020-2025)

7.4 Europe Platinum Anti-tumor Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Platinum Anti-tumor Drugs Market Size (2020-2031)

8.2 Asia-Pacific Platinum Anti-tumor Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Platinum Anti-tumor Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Platinum Anti-tumor Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Platinum Anti-tumor Drugs Market Size (2020-2031)

9.2 Latin America Platinum Anti-tumor Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Platinum Anti-tumor Drugs Market Size by Country (2020-2025)

9.4 Latin America Platinum Anti-tumor Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Platinum Anti-tumor Drugs Market Size (2020-2031)

10.2 Middle East & Africa Platinum Anti-tumor Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Platinum Anti-tumor Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Platinum Anti-tumor Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Platinum Anti-tumor Drugs Introduction

11.1.4 Sanofi Revenue in Platinum Anti-tumor Drugs Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 Hengrui Medicine

11.2.1 Hengrui Medicine Company Details

11.2.2 Hengrui Medicine Business Overview

11.2.3 Hengrui Medicine Platinum Anti-tumor Drugs Introduction

11.2.4 Hengrui Medicine Revenue in Platinum Anti-tumor Drugs Business (2020-2025)

11.2.5 Hengrui Medicine Recent Development

11.3 ASK Pharma

11.3.1 ASK Pharma Company Details

11.3.2 ASK Pharma Business Overview

11.3.3 ASK Pharma Platinum Anti-tumor Drugs Introduction

11.3.4 ASK Pharma Revenue in Platinum Anti-tumor Drugs Business (2020-2025)

11.3.5 ASK Pharma Recent Development

11.4 Yi Bai Pharmaceutical

11.4.1 Yi Bai Pharmaceutical Company Details

11.4.2 Yi Bai Pharmaceutical Business Overview

11.4.3 Yi Bai Pharmaceutical Platinum Anti-tumor Drugs Introduction

11.4.4 Yi Bai Pharmaceutical Revenue in Platinum Anti-tumor Drugs Business (2020-2025)

11.4.5 Yi Bai Pharmaceutical Recent Development

11.5 Qilu Pharmaceutical

11.5.1 Qilu Pharmaceutical Company Details

11.5.2 Qilu Pharmaceutical Business Overview

11.5.3 Qilu Pharmaceutical Platinum Anti-tumor Drugs Introduction

11.5.4 Qilu Pharmaceutical Revenue in Platinum Anti-tumor Drugs Business (2020-2025)

11.5.5 Qilu Pharmaceutical Recent Development

11.6 Teva

11.6.1 Teva Company Details

11.6.2 Teva Business Overview

11.6.3 Teva Platinum Anti-tumor Drugs Introduction

11.6.4 Teva Revenue in Platinum Anti-tumor Drugs Business (2020-2025)

11.6.5 Teva Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Platinum Anti-tumor Drugs Introduction

11.7.4 Pfizer Revenue in Platinum Anti-tumor Drugs Business (2020-2025)

11.7.5 Pfizer Recent Development

11.8 Dr Reddy's Laboratories

11.8.1 Dr Reddy's Laboratories Company Details

11.8.2 Dr Reddy's Laboratories Business Overview

11.8.3 Dr Reddy's Laboratories Platinum Anti-tumor Drugs Introduction

11.8.4 Dr Reddy's Laboratories Revenue in Platinum Anti-tumor Drugs Business (2020-2025)

11.8.5 Dr Reddy's Laboratories Recent Development

11.9 Viatris

11.9.1 Viatris Company Details

11.9.2 Viatris Business Overview

11.9.3 Viatris Platinum Anti-tumor Drugs Introduction

11.9.4 Viatris Revenue in Platinum Anti-tumor Drugs Business (2020-2025)

11.9.5 Viatris Recent Development

11.10 Sun Pharma

11.10.1 Sun Pharma Company Details

11.10.2 Sun Pharma Business Overview

11.10.3 Sun Pharma Platinum Anti-tumor Drugs Introduction

11.10.4 Sun Pharma Revenue in Platinum Anti-tumor Drugs Business (2020-2025)

11.10.5 Sun Pharma Recent Development

11.11 Novartis

11.11.1 Novartis Company Details

11.11.2 Novartis Business Overview

11.11.3 Novartis Platinum Anti-tumor Drugs Introduction

11.11.4 Novartis Revenue in Platinum Anti-tumor Drugs Business (2020-2025)

11.11.5 Novartis Recent Development

11.12 Debiopharm

11.12.1 Debiopharm Company Details

11.12.2 Debiopharm Business Overview

11.12.3 Debiopharm Platinum Anti-tumor Drugs Introduction

11.12.4 Debiopharm Revenue in Platinum Anti-tumor Drugs Business (2020-2025)

11.12.5 Debiopharm Recent Development

11.13 Accord Healthcare

11.13.1 Accord Healthcare Company Details

11.13.2 Accord Healthcare Business Overview

11.13.3 Accord Healthcare Platinum Anti-tumor Drugs Introduction

11.13.4 Accord Healthcare Revenue in Platinum Anti-tumor Drugs Business (2020-2025)

11.13.5 Accord Healthcare Recent Development

11.14 SK Chemicals

11.14.1 SK Chemicals Company Details

11.14.2 SK Chemicals Business Overview

11.14.3 SK Chemicals Platinum Anti-tumor Drugs Introduction

11.14.4 SK Chemicals Revenue in Platinum Anti-tumor Drugs Business (2020-2025)

11.14.5 SK Chemicals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

Hengrui Medicine

ASK Pharma

Yi Bai Pharmaceutical

Qilu Pharmaceutical

TEVA

Pfizer Inc

Dr. Reddy’s Laboratories

Sun Pharma

Novartis

Debiopharm

Accord Healthcare

SK Chemicals

Viatris

List of Tables

Table 1. Global Platinum Anti-tumor Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cisplatin

Table 3. Key Players of Oxaliplatin

Table 4. Key Players of Carboplatin

Table 5. Key Players of Other

Table 6. Global Platinum Anti-tumor Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Platinum Anti-tumor Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Platinum Anti-tumor Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Platinum Anti-tumor Drugs Market Share by Region (2020-2025)

Table 10. Global Platinum Anti-tumor Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Platinum Anti-tumor Drugs Market Share by Region (2026-2031)

Table 12. Platinum Anti-tumor Drugs Market Trends

Table 13. Platinum Anti-tumor Drugs Market Drivers

Table 14. Platinum Anti-tumor Drugs Market Challenges

Table 15. Platinum Anti-tumor Drugs Market Restraints

Table 16. Global Platinum Anti-tumor Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Platinum Anti-tumor Drugs Market Share by Players (2020-2025)

Table 18. Global Top Platinum Anti-tumor Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platinum Anti-tumor Drugs as of 2024)

Table 19. Ranking of Global Top Platinum Anti-tumor Drugs Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Platinum Anti-tumor Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Platinum Anti-tumor Drugs, Headquarters and Area Served

Table 22. Global Key Players of Platinum Anti-tumor Drugs, Product and Application

Table 23. Global Key Players of Platinum Anti-tumor Drugs, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Platinum Anti-tumor Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Platinum Anti-tumor Drugs Revenue Market Share by Type (2020-2025)

Table 27. Global Platinum Anti-tumor Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Platinum Anti-tumor Drugs Revenue Market Share by Type (2026-2031)

Table 29. Global Platinum Anti-tumor Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Platinum Anti-tumor Drugs Revenue Market Share by Application (2020-2025)

Table 31. Global Platinum Anti-tumor Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Platinum Anti-tumor Drugs Revenue Market Share by Application (2026-2031)

Table 33. North America Platinum Anti-tumor Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Platinum Anti-tumor Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Platinum Anti-tumor Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Platinum Anti-tumor Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Platinum Anti-tumor Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Platinum Anti-tumor Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Platinum Anti-tumor Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Platinum Anti-tumor Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Platinum Anti-tumor Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Platinum Anti-tumor Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Platinum Anti-tumor Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Platinum Anti-tumor Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Platinum Anti-tumor Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Platinum Anti-tumor Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Platinum Anti-tumor Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 48. Sanofi Company Details

Table 49. Sanofi Business Overview

Table 50. Sanofi Platinum Anti-tumor Drugs Product

Table 51. Sanofi Revenue in Platinum Anti-tumor Drugs Business (2020-2025) & (US$ Million)

Table 52. Sanofi Recent Development

Table 53. Hengrui Medicine Company Details

Table 54. Hengrui Medicine Business Overview

Table 55. Hengrui Medicine Platinum Anti-tumor Drugs Product

Table 56. Hengrui Medicine Revenue in Platinum Anti-tumor Drugs Business (2020-2025) & (US$ Million)

Table 57. Hengrui Medicine Recent Development

Table 58. ASK Pharma Company Details

Table 59. ASK Pharma Business Overview

Table 60. ASK Pharma Platinum Anti-tumor Drugs Product

Table 61. ASK Pharma Revenue in Platinum Anti-tumor Drugs Business (2020-2025) & (US$ Million)

Table 62. ASK Pharma Recent Development

Table 63. Yi Bai Pharmaceutical Company Details

Table 64. Yi Bai Pharmaceutical Business Overview

Table 65. Yi Bai Pharmaceutical Platinum Anti-tumor Drugs Product

Table 66. Yi Bai Pharmaceutical Revenue in Platinum Anti-tumor Drugs Business (2020-2025) & (US$ Million)

Table 67. Yi Bai Pharmaceutical Recent Development

Table 68. Qilu Pharmaceutical Company Details

Table 69. Qilu Pharmaceutical Business Overview

Table 70. Qilu Pharmaceutical Platinum Anti-tumor Drugs Product

Table 71. Qilu Pharmaceutical Revenue in Platinum Anti-tumor Drugs Business (2020-2025) & (US$ Million)

Table 72. Qilu Pharmaceutical Recent Development

Table 73. Teva Company Details

Table 74. Teva Business Overview

Table 75. Teva Platinum Anti-tumor Drugs Product

Table 76. Teva Revenue in Platinum Anti-tumor Drugs Business (2020-2025) & (US$ Million)

Table 77. Teva Recent Development

Table 78. Pfizer Company Details

Table 79. Pfizer Business Overview

Table 80. Pfizer Platinum Anti-tumor Drugs Product

Table 81. Pfizer Revenue in Platinum Anti-tumor Drugs Business (2020-2025) & (US$ Million)

Table 82. Pfizer Recent Development

Table 83. Dr Reddy's Laboratories Company Details

Table 84. Dr Reddy's Laboratories Business Overview

Table 85. Dr Reddy's Laboratories Platinum Anti-tumor Drugs Product

Table 86. Dr Reddy's Laboratories Revenue in Platinum Anti-tumor Drugs Business (2020-2025) & (US$ Million)

Table 87. Dr Reddy's Laboratories Recent Development

Table 88. Viatris Company Details

Table 89. Viatris Business Overview

Table 90. Viatris Platinum Anti-tumor Drugs Product

Table 91. Viatris Revenue in Platinum Anti-tumor Drugs Business (2020-2025) & (US$ Million)

Table 92. Viatris Recent Development

Table 93. Sun Pharma Company Details

Table 94. Sun Pharma Business Overview

Table 95. Sun Pharma Platinum Anti-tumor Drugs Product

Table 96. Sun Pharma Revenue in Platinum Anti-tumor Drugs Business (2020-2025) & (US$ Million)

Table 97. Sun Pharma Recent Development

Table 98. Novartis Company Details

Table 99. Novartis Business Overview

Table 100. Novartis Platinum Anti-tumor Drugs Product

Table 101. Novartis Revenue in Platinum Anti-tumor Drugs Business (2020-2025) & (US$ Million)

Table 102. Novartis Recent Development

Table 103. Debiopharm Company Details

Table 104. Debiopharm Business Overview

Table 105. Debiopharm Platinum Anti-tumor Drugs Product

Table 106. Debiopharm Revenue in Platinum Anti-tumor Drugs Business (2020-2025) & (US$ Million)

Table 107. Debiopharm Recent Development

Table 108. Accord Healthcare Company Details

Table 109. Accord Healthcare Business Overview

Table 110. Accord Healthcare Platinum Anti-tumor Drugs Product

Table 111. Accord Healthcare Revenue in Platinum Anti-tumor Drugs Business (2020-2025) & (US$ Million)

Table 112. Accord Healthcare Recent Development

Table 113. SK Chemicals Company Details

Table 114. SK Chemicals Business Overview

Table 115. SK Chemicals Platinum Anti-tumor Drugs Product

Table 116. SK Chemicals Revenue in Platinum Anti-tumor Drugs Business (2020-2025) & (US$ Million)

Table 117. SK Chemicals Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Platinum Anti-tumor Drugs Picture

Figure 2. Global Platinum Anti-tumor Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Platinum Anti-tumor Drugs Market Share by Type: 2024 VS 2031

Figure 4. Cisplatin Features

Figure 5. Oxaliplatin Features

Figure 6. Carboplatin Features

Figure 7. Other Features

Figure 8. Global Platinum Anti-tumor Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Platinum Anti-tumor Drugs Market Share by Application: 2024 VS 2031

Figure 10. Colorectal Cancer Case Studies

Figure 11. Ovarian Cancer Case Studies

Figure 12. Lung Cancer Case Studies

Figure 13. Other Case Studies

Figure 14. Platinum Anti-tumor Drugs Report Years Considered

Figure 15. Global Platinum Anti-tumor Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Platinum Anti-tumor Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Platinum Anti-tumor Drugs Market Share by Region: 2024 VS 2031

Figure 18. Global Platinum Anti-tumor Drugs Market Share by Players in 2024

Figure 19. Global Top Platinum Anti-tumor Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platinum Anti-tumor Drugs as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Platinum Anti-tumor Drugs Revenue in 2024

Figure 21. North America Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Platinum Anti-tumor Drugs Market Share by Country (2020-2031)

Figure 23. United States Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Platinum Anti-tumor Drugs Market Share by Country (2020-2031)

Figure 27. Germany Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Platinum Anti-tumor Drugs Market Share by Region (2020-2031)

Figure 35. China Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Platinum Anti-tumor Drugs Market Share by Country (2020-2031)

Figure 43. Mexico Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Platinum Anti-tumor Drugs Market Share by Country (2020-2031)

Figure 47. Turkey Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Platinum Anti-tumor Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Sanofi Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2020-2025)

Figure 51. Hengrui Medicine Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2020-2025)

Figure 52. ASK Pharma Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2020-2025)

Figure 53. Yi Bai Pharmaceutical Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2020-2025)

Figure 54. Qilu Pharmaceutical Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2020-2025)

Figure 55. Teva Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2020-2025)

Figure 56. Pfizer Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2020-2025)

Figure 57. Dr Reddy's Laboratories Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2020-2025)

Figure 58. Viatris Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2020-2025)

Figure 59. Sun Pharma Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2020-2025)

Figure 60. Novartis Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2020-2025)

Figure 61. Debiopharm Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2020-2025)

Figure 62. Accord Healthcare Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2020-2025)

Figure 63. SK Chemicals Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Anti tumor Drug Market Research Report 2025

Tumor Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Platinum based Anticancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Antitumor Drugs Market Research Report 2025

Global Platinum based Cancer Drug Market Insights Forecast to 2030

Cancer Treatment Drugs Market

Global Breast Cancer Drugs Market Insights Forecast to 2030

Molecular Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology Small Molecule Drugs Market Insights Forecast to 2030

Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti tumor Injection Market Research Report 2024

Oncology Anti cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Platinum based Antineoplastic Market Research Report 2025

Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030

Global Platinum based Anticancer APIs Market Research Report 2024

Small Molecule Inhibitors for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antineoplastic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Drug based on PARP Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti Neoplastic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions